2018
DOI: 10.1053/j.semperi.2017.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Ethical and end of life considerations for neonates requiring ECMO support

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
57
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(57 citation statements)
references
References 60 publications
0
57
0
Order By: Relevance
“…This paper focuses on using ECPR for cerebral-CPR. In this context, ECMO technology is generally applied for the purpose of (1) bridge-to-recovery by providing time for diagnostic procedures and/or therapeutics to be delivered (e.g., acute arrhythmia following cardiac surgery, or from electrolyte disturbance with loss of cardiac output and refractory to conventional therapy, acute myocarditis with complex arrhythmias or heart block, patient with residual lesions after cardiac surgery who could undergo additional surgery or intervention in the catheterization laboratory); (2) bridge-to-organ transplantation or as a means to bridging to decision with another device—to consider organ transplantation; or for (3) bridge-to-decision , which includes decision to continue, decision to stop advanced technological support, and to bridge to palliative care plan ( 21 ).…”
Section: Patient Selectionmentioning
confidence: 99%
“…This paper focuses on using ECPR for cerebral-CPR. In this context, ECMO technology is generally applied for the purpose of (1) bridge-to-recovery by providing time for diagnostic procedures and/or therapeutics to be delivered (e.g., acute arrhythmia following cardiac surgery, or from electrolyte disturbance with loss of cardiac output and refractory to conventional therapy, acute myocarditis with complex arrhythmias or heart block, patient with residual lesions after cardiac surgery who could undergo additional surgery or intervention in the catheterization laboratory); (2) bridge-to-organ transplantation or as a means to bridging to decision with another device—to consider organ transplantation; or for (3) bridge-to-decision , which includes decision to continue, decision to stop advanced technological support, and to bridge to palliative care plan ( 21 ).…”
Section: Patient Selectionmentioning
confidence: 99%
“…23 Utilization of ECMO has resulted in ethical debates about autonomy, nonmaleficence, informed consent, resource allocation, and the advancement of medicine. 24,25 ECMO now has an expanded role including-at times-for patients with active malignancies who need short-term support to recovery, but this role can necessitate discussions of withdrawal of ECMO support if there is no clinical improvement. 26,27 A central ethical question in BJ's case is how to express regard for the child's best interest using emerging technology amidst disagreement between clinical team members and parental decision makers.…”
Section: Guidelines For Shared Decision Making About New Technology Usementioning
confidence: 99%
“…9 These laws are, however, not final, and more work must be done to create guidelines for stopping ECMO life support. 10 Ethics committee consultation should be taken, which can yield recommendations and some clarifying explanations that support the final decisions to end ECMO care among patient's family members and members of ECMO care team. This can delay unwarranted legal action.…”
Section: Do Not Resuscitate/dnar: Since the Original Inceptionmentioning
confidence: 99%